Michael Markowitz, Barrett Woods, Gregory Schroeder, Christopher Kepler, David Kaye, Mark Kurd, Joshua Armstrong, Alexander Vaccaro, Kris Radcliff
{"title":"A Novel Multimodal Postoperative Pain Protocol for 1- to 2-Level Open Lumbar Fusions: A Retrospective Cohort Study.","authors":"Michael Markowitz, Barrett Woods, Gregory Schroeder, Christopher Kepler, David Kaye, Mark Kurd, Joshua Armstrong, Alexander Vaccaro, Kris Radcliff","doi":"10.14444/8484","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There has been increased interest in exploring methods to reduce postoperative pain without opioid medications. In 2015, a multimodal analgesia protocol was used involving the perioperative use of celecoxib, gabapentin, intravenous acetaminophen, lidocaine, and liposomal bupivacaine. Overall, the goal was to reduce the utilization of scheduled opioids in favor of nonopioid pain management.</p><p><strong>Methods: </strong>The results of a consecutive series of 1- to 2-level open primary lumbar fusions were compared to a cohort of patients after the implementation the perioperative multimodal pain management protocol. Primary endpoints included patient-reported pain scores and secondary endpoints included length of stay.</p><p><strong>Results: </strong>There were 87 patients in the preprotocol cohort and 184 in the protocol cohort. Comparing protocol and preprotocol patients, there were no significant differences in patient demographics. There was significantly average lower pain in the protocol group on postoperative day (POD) 1 (4.50 vs 5.00, <i>P</i> < 0.02) and POD2 (4.42 vs 5.50, <i>P</i> < 0.03). There was a lower pain score on POD0 (4.80 vs 5.00), but it was only clinically significant. There was a correlation between pain and duration of surgery in the preprotocol patients (POD0 <i>R</i> = 0.23, POD1 <i>R</i> = 0.02, POD2 <i>R</i> = 0.38), but not in the protocol patients (POD0 <i>R</i> = -0.05, POD1 <i>R</i> = -0.08, POD2 <i>R</i> = -0.04). There was a shorter length of stay in the protocol cohort (2.0 vs 3.0, <i>P</i> < 0.01). Finally, there was an approximately 35% reduction in morphine milligram equivalents of opioids in the protocol vs preprotocol cohorts (36.2 vs 57.0, <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>Our novel multimodal pain management protocol significantly reduced postoperative pain, length of stay, and opioid consumption in this patient cohort. Opioid usage correlated to pain in the protocol patients, while the preprotocol patients had no correlation between opioid use and pain medication.</p><p><strong>Clinical relevance: </strong>In this study, we demonstrated that preoperative and intraoperative analgesia can reduce postoperative pain medication requirements. Furthermore, we introduced a novel concept of a correlation of pain with opioid consumption as a marker of effective pain management of breakthrough pain.</p><p><strong>Level of evidence: 4: </strong></p>","PeriodicalId":38486,"journal":{"name":"International Journal of Spine Surgery","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10753327/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Spine Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14444/8484","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: There has been increased interest in exploring methods to reduce postoperative pain without opioid medications. In 2015, a multimodal analgesia protocol was used involving the perioperative use of celecoxib, gabapentin, intravenous acetaminophen, lidocaine, and liposomal bupivacaine. Overall, the goal was to reduce the utilization of scheduled opioids in favor of nonopioid pain management.
Methods: The results of a consecutive series of 1- to 2-level open primary lumbar fusions were compared to a cohort of patients after the implementation the perioperative multimodal pain management protocol. Primary endpoints included patient-reported pain scores and secondary endpoints included length of stay.
Results: There were 87 patients in the preprotocol cohort and 184 in the protocol cohort. Comparing protocol and preprotocol patients, there were no significant differences in patient demographics. There was significantly average lower pain in the protocol group on postoperative day (POD) 1 (4.50 vs 5.00, P < 0.02) and POD2 (4.42 vs 5.50, P < 0.03). There was a lower pain score on POD0 (4.80 vs 5.00), but it was only clinically significant. There was a correlation between pain and duration of surgery in the preprotocol patients (POD0 R = 0.23, POD1 R = 0.02, POD2 R = 0.38), but not in the protocol patients (POD0 R = -0.05, POD1 R = -0.08, POD2 R = -0.04). There was a shorter length of stay in the protocol cohort (2.0 vs 3.0, P < 0.01). Finally, there was an approximately 35% reduction in morphine milligram equivalents of opioids in the protocol vs preprotocol cohorts (36.2 vs 57.0, P < 0.05).
Conclusion: Our novel multimodal pain management protocol significantly reduced postoperative pain, length of stay, and opioid consumption in this patient cohort. Opioid usage correlated to pain in the protocol patients, while the preprotocol patients had no correlation between opioid use and pain medication.
Clinical relevance: In this study, we demonstrated that preoperative and intraoperative analgesia can reduce postoperative pain medication requirements. Furthermore, we introduced a novel concept of a correlation of pain with opioid consumption as a marker of effective pain management of breakthrough pain.
背景:人们对探索在不使用阿片类药物的情况下减轻术后疼痛的方法越来越感兴趣。2015 年,采用了一种多模式镇痛方案,包括围手术期使用塞来昔布、加巴喷丁、静脉注射对乙酰氨基酚、利多卡因和脂质体布比卡因。总之,我们的目标是减少阿片类药物的使用,转而采用非阿片类药物止痛:方法:在实施围手术期多模式疼痛管理方案后,将一系列连续的1至2级开放式腰椎初次融合术的结果与一组患者进行比较。主要终点包括患者报告的疼痛评分,次要终点包括住院时间:结果:方案实施前队列中有 87 名患者,方案实施后队列中有 184 名患者。比较协议患者和协议前患者,在患者人口统计学方面没有明显差异。在术后第 1 天(POD)(4.50 vs 5.00,P < 0.02)和第 2 天(POD2)(4.42 vs 5.50,P < 0.03),协议组患者的平均疼痛程度明显降低。POD0的疼痛评分较低(4.80 vs 5.00),但仅具有临床意义。协议前患者的疼痛与手术时间之间存在相关性(POD0 R = 0.23,POD1 R = 0.02,POD2 R = 0.38),但协议患者的疼痛与手术时间之间不存在相关性(POD0 R = -0.05,POD1 R = -0.08,POD2 R = -0.04)。方案组患者的住院时间更短(2.0 vs 3.0,P < 0.01)。最后,方案队列与方案前队列相比,阿片类药物的吗啡毫克当量减少了约35%(36.2 vs 57.0,P < 0.05):我们的新型多模式疼痛管理方案大大减少了该组患者的术后疼痛、住院时间和阿片类药物用量。协议患者的阿片类药物使用量与疼痛相关,而协议前患者的阿片类药物使用量与止痛药物之间没有相关性:本研究表明,术前和术中镇痛可减少术后镇痛药物的需求量。此外,我们还提出了一个新概念,即疼痛与阿片类药物用量的相关性是有效控制突破性疼痛的标志:4:
期刊介绍:
The International Journal of Spine Surgery is the official scientific journal of ISASS, the International Intradiscal Therapy Society, the Pittsburgh Spine Summit, and the Büttner-Janz Spinefoundation, and is an official partner of the Southern Neurosurgical Society. The goal of the International Journal of Spine Surgery is to promote and disseminate online the most up-to-date scientific and clinical research into innovations in motion preservation and new spinal surgery technology, including basic science, biologics, and tissue engineering. The Journal is dedicated to educating spine surgeons worldwide by reporting on the scientific basis, indications, surgical techniques, complications, outcomes, and follow-up data for promising spinal procedures.